Fund Holdings — GENERAL ATLANTIC, L.P.

Total Portfolio Value:
$2.81B
Total Bought:
$14.59M
Total Sold:
$705.92M
Net Transaction:
-$691.33M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
DLocal LimitedCL A(DLO)63,906,69563,906,6950$511.25M$719.59M25.61%+$208.34M
Alignment Healthcare, Inc.(ALHC)60,993,32360,993,3230$720.94M$686.17M24.43%-$34.77M
Alkami Technology, Inc.(ALKT)15,520,3189,645,318-5,875,000$489.51M$353.79M12.59%-$135.72M
XP Inc.CL A(XP)29,617,73329,617,7330$531.34M$350.97M12.49%-$180.37M
Centessa PharmaceuticalsADS9,681,8189,681,8180$154.81M$162.17M5.77%+$7.36M
Akero Therapeutics5,233,9895,233,9890$150.16M$145.61M5.18%-$4.55M
Pharvaris
COM
7,531,2527,531,2520$139.48M$144.37M5.14%+$4.90M
European Wax CenterCL A
CLASS A COM
13,110,49213,110,4920$89.15M$87.45M3.11%-$1.70M
Royalty Pharma plcCL A(RPRX)1,500,0001,500,0000$42.44M$38.27M1.36%-$4.17M
Immunocore Holdings plcADS(IMCR)1,261,6841,261,6840$39.28M$37.22M1.32%-$2.06M
Third Harmonic Bio2,958,7623,372,323+413,561$40.09M$34.70M1.24%-$5.39M
Riskified Ltd.CL A(RSKD)5,324,9985,324,9980$25.19M$25.19M0.90%$0
Acelyrin2,889,6682,695,327-194,341$14.25M$8.46M0.30%-$5.78M
AdageneADS264,0003,825,952+3,561,952$586.1K$7.61M0.27%+$7.03M
WishCL A609,616609,6160$3.32M$4.29M0.15%+$963.2K
Grove Collaborative Holdings, Inc.CL A(GROV)936,0202,474,859+1,538,839$1.26M$3.44M0.12%+$2.18M
Blend Labs, Inc.CL A(BLND)19,132,4400-19,132,440$71.75M$0—-$71.75M
SquarespaceCL A10,611,0730-10,611,073$492.67M$0—-$492.67M
Page 1 of 1
GENERAL ATLANTIC, L.P. — 13F Holdings — Q4 2024 | TickerTrail